Illinois Municipal Retirement Fund Has $7.22 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Illinois Municipal Retirement Fund lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 16.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 95,324 shares of the company's stock after buying an additional 13,482 shares during the period. Illinois Municipal Retirement Fund owned 0.07% of Henry Schein worth $7,217,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HSIC. Lazard Asset Management LLC grew its position in Henry Schein by 1,303.3% in the 3rd quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company's stock worth $92,614,000 after purchasing an additional 1,158,451 shares during the last quarter. Boston Partners grew its position in Henry Schein by 4,975.9% in the 3rd quarter. Boston Partners now owns 1,080,598 shares of the company's stock worth $80,229,000 after purchasing an additional 1,059,309 shares during the last quarter. American Century Companies Inc. grew its position in Henry Schein by 7.3% in the 3rd quarter. American Century Companies Inc. now owns 4,719,088 shares of the company's stock worth $350,392,000 after purchasing an additional 322,649 shares during the last quarter. Artisan Partners Limited Partnership bought a new position in Henry Schein in the 3rd quarter worth about $19,864,000. Finally, Adage Capital Partners GP L.L.C. bought a new position in Henry Schein in the 3rd quarter worth about $16,650,000. Institutional investors own 96.62% of the company's stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the company's stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Trading Up 0.6 %

Shares of NASDAQ:HSIC traded up $0.45 during mid-day trading on Wednesday, hitting $73.21. The stock had a trading volume of 824,051 shares, compared to its average volume of 1,090,321. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The company has a market cap of $9.41 billion, a PE ratio of 23.24, a P/E/G ratio of 1.79 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $85.39. The company's 50 day moving average is $74.29 and its 200-day moving average is $72.43.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). The firm had revenue of $3.02 billion during the quarter, compared to analysts' expectations of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm's revenue was down 10.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.21 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 5.07 EPS for the current year.

Analysts Set New Price Targets

HSIC has been the subject of several recent analyst reports. Evercore ISI upped their target price on shares of Henry Schein from $79.00 to $83.00 and gave the stock an "in-line" rating in a research report on Wednesday, February 28th. TheStreet upgraded shares of Henry Schein from a "c+" rating to a "b-" rating in a report on Monday, February 26th. Piper Sandler increased their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an "overweight" rating in a report on Monday, February 26th. Jefferies Financial Group increased their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the company a "hold" rating in a report on Wednesday, March 6th. Finally, Barrington Research increased their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a report on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has an average rating of "Hold" and an average price target of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.